Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IIITerminatedAug 28, 2013NataChewSubpotent; Beta carotene (Vitamin A)Stayma Consulting Service, LLC. · D-897-2013Class IIITerminatedAug 28, 2013Duet DHA 400 ecSubpotent; Beta carotene (Vitamin A)Stayma Consulting Service, LLC. · D-896-2013Class IIITerminatedAug 28, 2013Duet DHA 400Subpotent; Beta carotene (Vitamin A)Stayma Consulting Service, LLC. · D-895-2013Class IIITerminatedAug 28, 2013Duet DHA BalancedSubpotent; Beta carotene (Vitamin A)Stayma Consulting Service, LLC. · D-894-2013Class IITerminatedAug 21, 2013REEVA (triclosan) Antibacterial Hand Soap and Dishwashing LiquidMicrobial Contamination of a Non-Sterile Products: Product was found to be contaminated with the bacteria, Sarcina Lutea.Showline Automotive Products, Inc. dba US Soaps Mfg. Company · D-893-2013Class IIITerminatedAug 21, 2013buPROPion Hydrochloride Extended Release TabletsFailed Stability Specifications; out of specification results at the 9 month stability time point for color, dissolution and related compounds.American Health Packaging · D-892-2013Class IITerminatedAug 21, 2013(No Brand) First Aid KitCGMP Deviations: The first aid kits that are subject to the voluntary recall is being initiated due to failure in stability testing of the active ingredient Benzalkonium...Total Resources Intl · D-891-2013Class IITerminatedAug 21, 2013Medi-First Brand First Aid KitCGMP Deviations: The first aid kits that are subject to the voluntary recall is being initiated due to failure in stability testing of the active ingredient Benzalkonium...Total Resources Intl · D-890-2013Class IITerminatedAug 21, 20133M Tekk Brand Industrial/Construction First Aid KitCGMP Deviations: The first aid kits that are subject to the voluntary recall is being initiated due to failure in stability testing of the active ingredient Benzalkonium...Total Resources Intl · D-889-2013Class IIITerminatedAug 21, 2013Clobetasol Propionate CreamLabeling: Label Mix-up; some cartons labeled as Clobetasol Propionate Cream USP contain tubes labeled as Clobetasol Propionate Gel USP. The actual product in the tube is...Hi-Tech Pharmacal Co., Inc. · D-888-2013Class IITerminatedAug 21, 2013Propofol Injectable EmulsionPresence of Particulate Matter; single visible particulate was identified during a retain sample inspection identified as stainless steelHospira Inc. · D-887-2013Class IITerminatedAug 21, 2013RifadinSubpotent Drug: During review of retain samples, the manufacturer observed low fill in some capsules, which was related to an issue detected with the encapsulating...Sanofi-Synthelabo · D-886-2013Class IITerminatedAug 21, 2013GastrografinPresence of foreign substance: One lot of the product may contain black foreign particlesBracco Diagnostics Inc · D-885-2013Class IITerminatedAug 21, 2013Ranitidine Hydrochloride TabletsMicrobial Contamination of Non-Sterile Products: A lot of raw material used in the manufacture of Ranitidine was positive for Pseudomonas sp.Dr. Reddy's Laboratories, Inc. · D-884-2013Class IITerminatedAug 21, 2013Belladonna Alkaloids with Phenobarbital TabletsPresence of Foreign Substance: black specks comprised of degraded organic material found on tabletsWest-Ward Pharmaceutical Corp. · D-883-2013Class IIITerminatedAug 21, 2013Prednisone Tablet USPLabeling: Missing Label; missing label on blister cardBoehringer Ingelheim Roxane Inc · D-882-2013Class IITerminatedAug 21, 2013Verapamil InjectionLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurancePallimed Solutions · D-881-2013Class IITerminatedAug 21, 2013Vancomycin Ophthalmic PFLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurancePallimed Solutions · D-880-2013Class IITerminatedAug 21, 2013Trimix InjectionLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurancePallimed Solutions · D-879-2013Class IITerminatedAug 21, 2013Testosterone Cypionate InjectionLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurancePallimed Solutions · D-878-2013Class IITerminatedAug 21, 2013Testosterone Cypionate/Propionate InjectionLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurancePallimed Solutions · D-877-2013Class IITerminatedAug 21, 2013Testosterone Cypionate/Testosterone Enanthate InjectionLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurancePallimed Solutions · D-876-2013Class IITerminatedAug 21, 2013Tacrolimus OphthalmicLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurancePallimed Solutions · D-875-2013Class IITerminatedAug 21, 2013Quadmix InjectionLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurancePallimed Solutions · D-874-2013Class IITerminatedAug 21, 2013Nandrolone Decanoate InjectableLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurancePallimed Solutions · D-873-2013Class IITerminatedAug 21, 2013MIC with B6 and B12Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurancePallimed Solutions · D-872-2013Class IITerminatedAug 21, 2013Methylcobalamin PFLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurancePallimed Solutions · D-871-2013Class IITerminatedAug 21, 2013Hydroxyprogesterone CAPRLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurancePallimed Solutions · D-870-2013Class IITerminatedAug 21, 2013HCG Chorionic GonadotropinLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurancePallimed Solutions · D-869-2013Class IITerminatedAug 21, 2013Gentamicin Sulfate IrrigationLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurancePallimed Solutions · D-868-2013Class IITerminatedAug 21, 2013DMSO Aqueous Irrigation 50%Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurancePallimed Solutions · D-867-2013Class IITerminatedAug 21, 2013Dexamethasone PFLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurancePallimed Solutions · D-866-2013Class IITerminatedAug 21, 2013Diazepam InjectableLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurancePallimed Solutions · D-865-2013Class IITerminatedAug 21, 2013Cyclosporine OphthalmicLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurancePallimed Solutions · D-864-2013Class IITerminatedAug 21, 2013Cidofovir Opthalmic SolutionLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurancePallimed Solutions · D-863-2013Class IITerminatedAug 21, 2013Buprenorphine HCl Veterinary InjectionLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurancePallimed Solutions · D-862-2013Class IITerminatedAug 21, 2013BiMix InjectionLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurancePallimed Solutions · D-861-2013Class IITerminatedAug 21, 2013Bacteriostatic Water for InjectionLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurancePallimed Solutions · D-860-2013Class IITerminatedAug 21, 2013Atropine InjectionLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurancePallimed Solutions · D-859-2013Class IITerminatedAug 21, 2013Alprostadil IN NS InjectionLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurancePallimed Solutions · D-858-2013